Leukapheresis Market

Terumo BCT and HemaCare Corporation are Leading Players in Leukapheresis Market

Terumo BCT (US), Fresenius (Germany), Asahi Kasei Medical (Japan), and Haemonetics Corporation (US) are the leading players in the leukapheresis products market. The global leukapheresis products market is projected to reach USD 27.7 million by 2023 from USD 19.4 million in 2018, at a CAGR of 7.4%. HemaCare Corporation (US), AllCells (US), BioIVT (US), and Precision for Medicine (US) are the leading players in the leukopaks market. The global leukopaks market is projected to reach USD 445.6 million by 2023, at a CAGR of 46.4%.

Factors such as rising incidence and prevalence of leukemia and a growing demand for leukopaks are the key factors driving the growth of the leukapheresis market. In addition, the number of blood donations has grown in recent years, thereby ensuring the steady uptake of apheresis for the separation of blood components. The use of leukapheresis in pediatric patients is also being explored, making this an area of opportunity in the market. However, the high cost of therapeutic leukapheresis and leukopaks, the stringent regulations for leukocyte donor recruitment, and complications associated with therapeutic leukapheresis may restrain the growth of this market to a certain extent.

Major players in the global leukapheresis products market include Asahi Kasei Medical. (Japan), Fresenius SE & (Germany), Haemonetics (US), Terumo BCT (US), STEMCELL Technologies (Canada), Macopharma (France), Nikkiso (Japan), and Miltenyi Biotec (Germany). Some prominent players in the global leukopaks market are HemaCare Corporation (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US). These companies adopted strategies such as acquisitions, partnerships, agreements, collaborations, expansions, and product launches to enhance their presence in the leukapheresis products and leukopaks market.

To know about the assumptions considered for the study download the pdf brochure

Terumo BCT is a leading player in the leukapheresis products market and accounted for the largest share of the market in 2017. The company offers apheresis equipment with the WBC removal protocol. The company has a strong geographic presence through its various subsidiaries established across the globe—Terumo BCT Latin America S.A. in Argentina, Terumo BCT Europe N.V. in Belgium, and Terumo BCT (Asia Pacific) Ltd. in Hong Kong. The company focuses on expanding its presence to new and emerging economies like Vietnam, Belgium, and Northern Ireland. In July 2014, the company opened a manufacturing facility near Ho Chi Minh City, Vietnam.

HemaCare Corporation accounted for the largest share in leukopaks market in 2017. The company grew by 45.6% in 2017 compared to the previous year. This growth was mainly driven by international expansions and improved sales from the company’s key distributors, i.e. direct cell therapy customers, such as Novartis. The company’s business in Europe, Japan, and China is growing substantially. HemaCare also focuses on increasing its scalability in terms of quantity and quality to support the growing demand for leukopaks from research organizations for the development of cellular therapy technologies.

Related Reports:

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute) - Global Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
MD 6538
RI Published ON
8/14/2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Leukapheresis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved